Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome (2012)

  • Authors:
  • USP affiliated authors: TONE, LUIZ GONZAGA - FMRP ; QUEIROZ, ROSANE GOMES DE PAULA - FMRP ; SCRIDELI, CARLOS ALBERTO - FMRP
  • USP Schools: FMRP; FMRP; FMRP
  • DOI: 10.1007/s11010-011-1220-8
  • Subjects: POLIMORFISMO; RISCO; LEUCEMIA; INFÂNCIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s11010-011-1220-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Molecular and Cellular Biochemistry

    ISSN: 0300-8177

    Citescore - 2017: 2.71

    SJR - 2017: 1.003

    SNIP - 2017: 0.806


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2267829pcd 2267829 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVEIRA, Vanessa S.; CANALLE, Renata; SCRIDELI, Carlos Alberto; et al. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry, Secaucus, 2012. Disponível em: < http://dx.doi.org/10.1007/s11010-011-1220-8 > DOI: 10.1007/s11010-011-1220-8.
    • APA

      Silveira, V. S., Canalle, R., Scrideli, C. A., Queiroz, R. G. de P., Lopes, L. F., & Tone, L. G. (2012). CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome. Molecular and Cellular Biochemistry. doi:10.1007/s11010-011-1220-8
    • NLM

      Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;Available from: http://dx.doi.org/10.1007/s11010-011-1220-8
    • Vancouver

      Silveira VS, Canalle R, Scrideli CA, Queiroz RG de P, Lopes LF, Tone LG. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome [Internet]. Molecular and Cellular Biochemistry. 2012 ;Available from: http://dx.doi.org/10.1007/s11010-011-1220-8

    Referências citadas na obra
    Greaves M (1999) Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 35:1941–1953
    Pui CH (2000) Acute lymphoblastic leukemia in children. Curr Opin Oncol 12:3–12
    Bolufer P, Barragan E, Collado M, Cervera J, López JA, Sanz MA (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471–1491
    Canalle R, Burim RV, Tone LG, Takahashi CS (2004) Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ Mol Mutagen 43:100–109
    Silveira VS, Canalle R, Scrideli CA, Queiroz RG, Tone LG (2010) Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 51(1):48–56
    van Iersel ML, Verhagen H, van Bladeren PJ (1999) The role of biotransformation in dietary (anti)carcinogenesis. Mutat Res 443:259–270
    Brockmoller J, Cascorbi I, Henning S, Meisel C, Roots I (2000) Molecular genetics of cancer susceptibility. Pharmacology 61:212–227
    Lewis DFV, Watson E, Lake BG (1998) Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics. Mutat Res 410:245–270
    Amador AG, Righi PD, Radpour S, Everett ET, Weisberger E, Langer M, Eckert GJ, Christen AG, Campbell S Jr, Summerlin DJ, Reynolds N, Hartsfield JK Jr (2002) Polymorphisms of xenobiotic metabolizing genes in oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:440–445
    Agundez JA (2004) Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 5(3):211–224
    Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U (2006) Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 81:162–170
    Chen HC, Hu WX, Liu QX, Li WK, Chen FZ, Rao ZZ, Liu XF, Luo YP, Cao YF (2008) Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev 17(3):251–258
    Meeker ND, Yang JJ, Schiffman JD (2010) Pharmacogenomics of pediatric acute lymphoblastic leukemia. Expert Opin Pharmacother 11(10):1621–1632
    Rendic S, Di Carlo FJ (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev 29:413–580
    Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, Watkins PB, Daly A, Wrighton SA, Hall SD, Maurel P, Relling M, Brimer C, Yasuda K, Venkataramanan R, Strom S, Thummel K, Boguski MS, Schuetz E (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383–391
    Yamada S, Tang M, Richardson K, Halaschek-Wiener J, Chan M, Cook VJ, Fitzgerald JM, Elwood RK, Brooks-Wilson A, Marra F (2009) Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population. Pharmacogenomics 10(9):1433–1445
    Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D (2000) Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene–gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 9:557–562
    Canalle R, Silveira VS, Scrideli CA, Queiroz RG, Lopes LF, Tone LG (2011) Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma 52(6):1118–1126
    Cascorbi I, Brockmoller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I (1996) Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 56:3961–3966
    van Schaik RH, van der Heiden IP, van den Anker JN, Lindemans J (2002) CYP3A5 variant allele frequencies in Dutch Caucasians. Clin Chem 48:1668–1671
    Sailaja K, Rao DN, Rao DR, Vishnupriya S (2010) Analysis of CYP3A5*3 and CYP3A5*6 gene polymorphisms in Indian chronic myeloid leukemia patients. Asian Pac J Cancer Prev 11(3):781–784
    Borst L, Wallerek S, Dalhoff K, Rasmussen KK, Wesenberg F, Wehner PS, Schmiegelow K (2011) The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia. Eur J Haematol 86(6):477–483. doi: 10.1111/j.1600-0609.2011.01608.x
    Pakakasama S, Mukda E, Sasanakul W, Kadegasem P, Udomsubpayakul U, Thithapandha A, Hongeng S (2005) Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am J Hematol 79:202–205
    Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV (2002) Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12:605–611
    Liu TC, Lin SF, Chen TP, Chang JG (2002) Polymorphism analysis of CYP3A5 in myeloid leukemia. Oncol Rep 9:327–329
    Aplenc R, Glatfelter W, Han P, Rappaport E, La M, Cnaan A, Blackwood MA, Lange B, Rebbeck T (2003) CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia. Br J Haematol 122:240–244
    Lemos MC, Cabrita FJ, Silva HA, Vivan M, Placido F, Regateiro FJ (1999) Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 20:1225–1229
    Rollinson S, Roddam P, Willett E, Roman E, Cartwright R, Jack A, Morgan GJ (2001) NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study. Cancer Epidemiol Biomarkers Prev 10:567–568
    Zanrosso CW, Hatagima A, Emerenciano M, Ramos F, Figueiredo A, Félix TM, Segal SL, Guigliani R, Muniz MT, Pombo-de-Oliveira MS (2006) The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 30:477–481
    Gra OA, Glotov AS, Kozhekbaeva Zh, Makarova OV, Nasedkina TV (2008) Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol Mosk 42(2):214–225